African Leaders' Malaria Alliance (ALMA) Company Profile
News Articles
African leaders reaffirm commitment to eliminate malaria at African Union summit
"African leaders have reaffirmed their commitment to efforts to eliminate malaria, after they were informed that unprecedented success in scaling up malaria control interventions resulted in one-third...
Malaria experts join forces with Novartis to empower local communities to tackle malaria in Africa
The Novartis Malaria Initiative is convening global experts from education, government, community health and economics to share best practices and empower local African communities to deliver sustaina...
Sustained funding for malaria efforts needed to maintain momentum
"When in the year 2000 African leaders first decided to put a Malaria Day on the calendar of the world, the ravages of malaria were barely visible to global decision-makers in prosperous countries," F...
African leaders renew commitment to providing HIV treatment, prevention services
"African leaders meeting on the sidelines of the 67th session of the United Nations General Assembly called Wednesday for innovative solutions to accelerate the response to AIDS, tuberculosis and mala...
RTS,S malaria candidate vaccine reduces malaria by approximately one-third in African infants
(Burness Communications) Results from a pivotal, large-scale Phase III trial, published online today in the New England Journal of Medicine, show that the RTS,S malaria vaccine candidate can help prot...
International African Vaccinology Conference, Cape Town, South Africa - Results from a pivotal, large-scale Phase III trial, published online in the New England Journal of Medicine, show that the RTS,...
Setback for first malaria vaccine in African trial
LONDON (Reuters) - The world's first potential malaria vaccine proved only 30 percent effective in African babies in a crucial trial, calling into question whether it can be a useful weapon in the fig...
RTS,S vaccine candidate can help protect African infants against malaria
International African Vaccinology Conference, Cape Town, South Africa-Results from a pivotal, large-scale Phase III trial, published online today in the New England Journal of Medicine, show that the...
Drugs and Medications
Oxygen [Alliance Welding Supplies Inc dba Atlas Welding Supply]
Oxygen Label
Pca skin acne [Physicians Care Alliance dba PCA Skin]
PCA SKIN Acne Gel
Nitrogen [Alliance Welding Supplies Inc dba Atlas Welding Supply]
Nitrogen Label
PubMed Articles
This study explores HIV/AIDS communication strategies among church leaders at predominately African American churches in a metropolitan city and surrounding areas in North Carolina. The church leaders...
The Gates Malaria Partnership: a consortium approach to malaria research and capacity development.
Recently, there has been a major increase in financial support for malaria control. Most of these funds have, appropriately, been spent on the tools needed for effective prevention and treatment of ma...
This manuscript examines the HIV/AIDS health disparity among African-American (AA) men who have sex with men (MSM) as compared to non-Hispanic White (NHW) MSM, and proposes faith-based intervention st...
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children.
Background An ongoing phase 3 study of the efficacy, safety, and immunogenicity of candidate malaria vaccine RTS,S/AS01 is being conducted in seven African countries. Methods From March 2009...
Malaria Vaccine Trials - Beyond Efficacy End Points.
Plasmodium falciparum infection, malaria, continues to cause more than 1 million childhood deaths each year.(1) In addition, millions of nonlethal infections affect communities on an economic basis an...
Clinical Trials
Mannitol as Adjunct Therapy for Childhood Cerebral Malaria
Cerebral malaria is a life-threatening complication of Plasmodium falciparum infection in African children and nonimmune travellers despite availability of quinine, the current drug of cho...
The primary objective is to assess the safety of different doses of ferroquine with artesunate (AS) in adult African patients with uncomplicated malaria. The secondary objectives are to a...
Malaria Prevalence in Children
The purpose of this pilot study is to evaluate the use of (1) 'malaria prevalence', (2) 'malaria incidence' and (3) 'malaria mortality' as a measure of malaria transmission in The Gambia,...
This study will assess the safety and efficacy of artemether-lumefantrine tablets (6-dose regimen) in African infants / children with acute uncomplicated falciparum malaria.
An investigation will be made of the combined impact of insecticide-treated nets and intermittent preventive treatment with amodiaquine + sulfadoxine-pyrimethamine on malaria morbidity in...
Companies
African Leaders' Malaria Alliance (ALMA)
African Leaders Malaria Alliance
Every day, ALMA has an extensive and varied menu assortment. Click on the name of a specific ALMA restaurant to see the menus for that location. You can also view the menus for the week for all locati...
Malaria has become one of the world’s most devastating problems. The disease accounts for 1.5 to 2.7 millions deaths, of which about 1.0 million are African children, each year.Our mission is to cur...
Alma Lasers is a global developer, manufacturer and provider of laser, light-based, radiofrequency and ultrasound devices for aesthetic and medical applications. Alma Lasers has been at the forefront...
More Information about "African Leaders' Malaria Alliance (ALMA)" on BioPortfolio
We have published hundreds of African Leaders' Malaria Alliance (ALMA) news stories on BioPortfolio along with dozens of African Leaders' Malaria Alliance (ALMA) Clinical Trials and PubMed Articles about African Leaders' Malaria Alliance (ALMA) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of African Leaders' Malaria Alliance (ALMA) Companies in our database. You can also find out about relevant African Leaders' Malaria Alliance (ALMA) Drugs and Medications on this site too.
